El-Baba C.; Mahadevan V.; Fahlbusch F.B.; S S.M.; Rau T.T.; Gali-Muhtasib H.; Schneider-Stock R.
(BioMed Central Ltd.; LONDON236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND, 2014)
Background: Thymoquinone (TQ) was shown to reduce tumor growth in several cancer models both in vitro and in vivo. So far only a few targets of TQ, including protein kinases have been identified. Considering that kinases ...